Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline A Lindemans

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Blood|August 28, 2025
Hole in one: CD137-ADC eliminates GVHDStefan Nierkens, Caroline A Lindemans
Cytotherapy|March 21, 2015
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cellsCaroline A Lindemans, Koen van Besien
Blood|August 9, 2014
The importance of bone marrow involvement in GVHDCaroline A Lindemans, Alan M Hanash
Advances in Experimental Medicine and Biology|August 19, 2005
The immune response to viral lower respiratory tract infectionCaroline A Lindemans, Jan L L Kimpen
Blood|September 15, 2010
How I treat adenovirus in hematopoietic stem cell transplant recipientsCaroline A Lindemans, Ann M Leen, Jaap Jan Boelens
Cells|August 27, 2021
Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?Konradin F Müskens, Caroline A Lindemans, Mirjam E Belderbos
Cellular Immunology|November 21, 2024
Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potentialEva M Gossink, Paul J Coffer, Alessandro Cutilli, et al.
Frontiers in Immunology|July 7, 2022
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?Linde Dekker, Evy Sanders, Caroline A Lindemans, et al.
Blood Advances|November 26, 2025
Fludarabine dosing in the youngest children: safety firstRick Admiraal, Shelby Barnett, Caroline A Lindemans, et al.
Frontiers in Immunology|April 1, 2022
Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing PolychondritisSaskia R Veldkamp, Marc H A Jansen, Joost F Swart, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Blood|August 28, 2025
Hole in one: CD137-ADC eliminates GVHDStefan Nierkens, Caroline A Lindemans
Cytotherapy|March 21, 2015
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cellsCaroline A Lindemans, Koen van Besien
Blood|August 9, 2014
The importance of bone marrow involvement in GVHDCaroline A Lindemans, Alan M Hanash
Advances in Experimental Medicine and Biology|August 19, 2005
The immune response to viral lower respiratory tract infectionCaroline A Lindemans, Jan L L Kimpen
Blood|September 15, 2010
How I treat adenovirus in hematopoietic stem cell transplant recipientsCaroline A Lindemans, Ann M Leen, Jaap Jan Boelens
Cells|August 27, 2021
Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?Konradin F Müskens, Caroline A Lindemans, Mirjam E Belderbos
Cellular Immunology|November 21, 2024
Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potentialEva M Gossink, Paul J Coffer, Alessandro Cutilli, et al.
Frontiers in Immunology|July 7, 2022
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?Linde Dekker, Evy Sanders, Caroline A Lindemans, et al.
Blood Advances|November 26, 2025
Fludarabine dosing in the youngest children: safety firstRick Admiraal, Shelby Barnett, Caroline A Lindemans, et al.
Frontiers in Immunology|April 1, 2022
Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing PolychondritisSaskia R Veldkamp, Marc H A Jansen, Joost F Swart, et al.
Pageof 10